Eurizon Capital SGR S.p.A. purchased a new position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 35,002 shares of the technology company’s stock, valued at approximately $7,816,000.
A number of other institutional investors have also recently bought and sold shares of VEEV. Sivia Capital Partners LLC boosted its stake in Veeva Systems by 225.9% during the second quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock worth $899,000 after buying an additional 2,164 shares in the last quarter. Bank of Nova Scotia boosted its stake in Veeva Systems by 44.5% during the second quarter. Bank of Nova Scotia now owns 5,866 shares of the technology company’s stock worth $1,689,000 after buying an additional 1,806 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Veeva Systems by 34.6% during the second quarter. NewEdge Advisors LLC now owns 8,832 shares of the technology company’s stock valued at $2,543,000 after acquiring an additional 2,272 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of Veeva Systems by 2.2% during the second quarter. Treasurer of the State of North Carolina now owns 68,950 shares of the technology company’s stock valued at $19,856,000 after acquiring an additional 1,452 shares during the period. Finally, Diversify Wealth Management LLC lifted its holdings in shares of Veeva Systems by 5.3% during the second quarter. Diversify Wealth Management LLC now owns 11,399 shares of the technology company’s stock valued at $3,140,000 after acquiring an additional 575 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.
Key Veeva Systems News
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva announced that Kindeva, a global CDMO, is adopting Veeva Quality Cloud to unify sites on a single platform, which supports Veeva’s growth narrative and could boost future recurring software revenue. Why Veeva Systems (VEEV) Stock Is Up Today
- Positive Sentiment: Coverage highlighting Veeva versus IQVIA points to strong industry tailwinds from life sciences digitization, with Veeva viewed as benefiting from AI adoption and a premium business model. Veeva vs. IQVIA: Which Life Sciences Tech Stock Holds More Promise?
- Neutral Sentiment: Several articles previewed Wall Street’s key metric estimates for Veeva’s upcoming quarter, suggesting investors are watching whether the company can meet growth expectations, but these pieces did not include a new earnings surprise or guidance update. Unveiling Veeva (VEEV) Q1 Outlook: Wall Street Estimates for Key Metrics
- Neutral Sentiment: Veeva was also highlighted as a trending stock and covered in analyst-style writeups noting a “Moderate Buy” consensus, which supports attention on the name but does not by itself change fundamentals. Veeva Systems Inc. (NYSE:VEEV) Given Average Recommendation of “Moderate Buy” by Analysts
Veeva Systems Stock Down 0.2%
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business had revenue of $835.95 million during the quarter, compared to analysts’ expectations of $810.95 million. During the same period in the previous year, the business posted $1.74 earnings per share. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, sell-side analysts anticipate that Veeva Systems Inc. will post 6.45 EPS for the current year.
Insider Activity
In related news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director directly owned 3,253 shares of the company’s stock, valued at $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on VEEV. William Blair reissued an “outperform” rating on shares of Veeva Systems in a report on Tuesday, March 10th. Piper Sandler cut their price objective on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. Wells Fargo & Company cut their price objective on Veeva Systems from $333.00 to $317.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. UBS Group lifted their price objective on Veeva Systems from $200.00 to $220.00 and gave the company a “neutral” rating in a report on Thursday, March 5th. Finally, Wall Street Zen cut Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. Sixteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $276.52.
Get Our Latest Stock Report on VEEV
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
